4 photos

• Sort by: number of views (most to least) number of views (least to most) number of comments (most to least) number of comments (least to most) number of favorites (most to least) number of favorites (least to most) date uploaded (newest first) date uploaded (oldest first) random

• Figure 4: Distribution of Critical Shortages of Drugs Containing Controlled Substances by Therapeutic Class and Product Type, January 2001 through June 2013

  • Uploaded by: U.S. Government Accountability Office
  • License: United States Government Work
  • 0 comments
  • 0 favorites
  • 2,086 views
  • Date uploaded: 2015-03-23
  • Tags: gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao15202, drugshortages, adhd, attentiondeficithyperactivitydisorder, api, activepharmaceuticalingredient, apq, aggregateproductionquota, arcos, automationofreportsandconsolidatedorderssystem, csa, controlledsubstancesact, dea, drugenforcementadministration, doj, departmentofjusticedssdrugshortagestaff, ems, emergencymedicalservices, fda, foodanddrugadministration, fdasia, foodanddrugadministrationsafetyandinnovationact, gpra, governmentperformanceandresultsactof1993, hhs, departmentofhealthandhumanservices, mou, memorandumofunderstanding, uudis, universityofutahdruginformationservice, yersqms, yearendreportingandquotamanagementsystem
  • Visibility: public
• Figure 1: Food and Drug Administration (FDA) Centers and Offices with Targeted Regulatory Science Projects Related to Medical Products, as of February 2016

  • Uploaded by: U.S. Government Accountability Office
  • License: United States Government Work
  • 0 comments
  • 0 favorites
  • 2,022 views
  • Date uploaded: 2016-07-01
  • Tags: gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao16432, medicalproductoversight, cber, centerforbiologicsevaluationandresearch, cder, centerfordrugevaluationandresearch, cdrh, centerfordevicesandradiologicalhealth, fda, foodanddrugadministration, fdasia, foodanddrugadministrationsafetyandinnovationactof2012, gdufa, genericdruguserfeeamendmentsof2012, gpra, governmentperformanceandresultsactof1993, hhs, departmentofhealthandhumanservices, nctr, nationalcenterfortoxicologicalresearch, ocet, officeofcounterterrorismandemergingthreats, oip, officeofinternationalprograms, omh, officeofminorityhealth, orsi, officeofregulatoryscienceandinnovation, owh, officeofwomenshealth, pdufa, prescriptiondruguserfeeact
  • Visibility: public
• Figure 2: Total Number of Food and Drug Administration (FDA) Medical Product Center Employees, Fiscal Years 2012 to 2015

  • Uploaded by: U.S. Government Accountability Office
  • License: United States Government Work
  • 1 comment
  • 0 favorites
  • 2,010 views
  • Date uploaded: 2016-07-01
  • Tags: gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao16500, foodanddrugadministration, bsufa, biosimilaruserfeeact, cber, centerforbiologicsevaluationandresearch, cder, centerfordrugevaluationandresearch, cdrh, centerfordevicesandradiologicalhealth, fda, fdasia, foodanddrugadministrationsafetyandinnovationactof2012, gdufa, genericdruguserfeeamendmentsact, gpra, governmentperformanceandresultsactof1993, hhs, departmentofhealthandhumanservices, mdufa, medicaldeviceuserfeeandmodernizationact, pdufa, prescriptiondruguserfeeactof1992, simp, strategicintegratedmanagementplan
  • Visibility: public
• Figure 1: The 10 Countries with the Most Foreign Drug Establishments Manufacturing Drugs for the U.S. Market as of June 2021

  • Uploaded by: U.S. Government Accountability Office
  • License: United States Government Work
  • 0 comments
  • 0 favorites
  • 1,128 views
  • Date uploaded: 2022-02-17
  • Tags: gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, drugsafety, gao22103611, api, activepharmaceuticalingredient, cder, centerfordrugevaluationandresearch, cgmp, currentgoodmanufacturingpractices, conops, conceptofoperations, covid19, coronavirusdisease2019, facts, fieldaccomplishmentsandcompliancetrackingsystem, fda, foodanddrugadministration, fdasia, foodanddrugadministrationsafetyandinnovationact, gdufa, genericdruguserfeeact, gs, generalschedule, hhs, departmentofhealthandhumanservices, nai, noactionindicated, oai, officialactionindicated, ogps, officeofglobalpolicyandstrategy, opm, officeofpersonnelmanagement, ora, officeofregulatoryaffairs, vai, voluntaryactionindicated
  • Visibility: public